ATE203396T1 - Spritzgegossene darreichungsform - Google Patents

Spritzgegossene darreichungsform

Info

Publication number
ATE203396T1
ATE203396T1 AT95937597T AT95937597T ATE203396T1 AT E203396 T1 ATE203396 T1 AT E203396T1 AT 95937597 T AT95937597 T AT 95937597T AT 95937597 T AT95937597 T AT 95937597T AT E203396 T1 ATE203396 T1 AT E203396T1
Authority
AT
Austria
Prior art keywords
injection
pharmaceutical form
molded pharmaceutical
poly
molded
Prior art date
Application number
AT95937597T
Other languages
English (en)
Inventor
Liang C Dong
Patrick S-L Wong
Crystal Pollock
Vincent Joseph Ferrari
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE203396T1 publication Critical patent/ATE203396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/48—Polyesters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95937597T 1994-10-28 1995-10-20 Spritzgegossene darreichungsform ATE203396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/330,892 US5614578A (en) 1994-10-28 1994-10-28 Injection-molded dosage form
PCT/US1995/013619 WO1996013248A1 (en) 1994-10-28 1995-10-20 Injection-molded dosage form

Publications (1)

Publication Number Publication Date
ATE203396T1 true ATE203396T1 (de) 2001-08-15

Family

ID=23291759

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00201378T ATE244554T1 (de) 1994-10-28 1995-10-20 Membranen aus thermoplastischen polymeren
AT95937597T ATE203396T1 (de) 1994-10-28 1995-10-20 Spritzgegossene darreichungsform

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00201378T ATE244554T1 (de) 1994-10-28 1995-10-20 Membranen aus thermoplastischen polymeren

Country Status (13)

Country Link
US (2) US5614578A (de)
EP (2) EP0782440B1 (de)
JP (1) JPH10508023A (de)
KR (2) KR100408103B1 (de)
AT (2) ATE244554T1 (de)
AU (1) AU695739B2 (de)
CA (1) CA2200746C (de)
CY (1) CY2489B1 (de)
DE (2) DE69521901T2 (de)
ES (1) ES2203395T3 (de)
NZ (1) NZ295982A (de)
WO (1) WO1996013248A1 (de)
ZA (1) ZA958892B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
US5773500A (en) * 1996-05-14 1998-06-30 Amoco Corporation Flame retardant high temperature polyphthalamides having improved thermal stability
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ATE325606T1 (de) * 1996-11-25 2006-06-15 Alza Corp Dosisform mit ansteigender dosisfreisetzung
WO1999018159A1 (en) * 1997-10-06 1999-04-15 Alza Corporation Injection-moldable composition and article of manufacture comprising same
US6251418B1 (en) 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
CN1296516A (zh) 1998-02-06 2001-05-23 联合碳化化学品及塑料技术公司 烯化氧聚合物组合物
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6183466B1 (en) 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
US6689121B1 (en) 1998-09-24 2004-02-10 C. R. Bard, Inc. Systems and methods for treating ischemia
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6432126B1 (en) 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6251079B1 (en) 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
DE69915346T2 (de) * 1998-12-17 2004-07-22 Alza Corp., Mountain View Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6719805B1 (en) * 1999-06-09 2004-04-13 C. R. Bard, Inc. Devices and methods for treating tissue
US6491683B1 (en) 1999-09-07 2002-12-10 Alza Corporation Osmotic dosage form composed of an extruded polymer tube form
ES2236012T3 (es) * 1999-12-09 2005-07-16 Alza Corporation Medicacion antiviral.
NZ518281A (en) * 1999-12-23 2005-01-28 Pfizer Prod Inc Controlled release drug dosage core comprising a drug-containing composition and a water-swellable composition
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
JP2002331522A (ja) * 2001-05-09 2002-11-19 Dai Ichi Kogyo Seiyaku Co Ltd 親水性樹脂粒状体の製造方法
GB0120835D0 (en) 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
US6767200B2 (en) * 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6742646B2 (en) 2001-09-28 2004-06-01 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
ATE376826T1 (de) * 2001-09-28 2007-11-15 Mcneil Ppc Inc Darreichungsformen zur modifizierten freisetzung
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
WO2003099214A2 (en) * 2002-05-23 2003-12-04 Andrx Corporation Biguanide formulations
US6583225B1 (en) * 2002-06-21 2003-06-24 Isp Investments Inc. Polymeric hydrogels
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
IL166023A0 (en) * 2002-06-28 2006-01-15 Alza Corp Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
WO2004010970A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
EP1556017A1 (de) * 2002-10-31 2005-07-27 ALZA Corporation Dosierungsform mit steigender freisetzung einer flüssigen formulierung
CN1728982A (zh) * 2002-10-31 2006-02-01 阿尔扎公司 可增加疏水性药物生物利用度的药物制剂
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
WO2005011630A2 (en) * 2003-07-31 2005-02-10 Alza Corporation Permeation-resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
CA2534920A1 (en) * 2003-08-06 2005-02-24 Alza Corporation Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
US20050136108A1 (en) * 2003-08-22 2005-06-23 Yam Noymi V. Stepwise delivery of topiramate over prolonged period of time
AU2004268661A1 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
JP4919801B2 (ja) * 2003-09-26 2012-04-18 アルザ・コーポレーシヨン 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
EP1663145B1 (de) * 2003-09-26 2011-04-06 ALZA Corporation Oros-push-stick für die kontrollierte abgabe von wirkstoffen
KR20120106757A (ko) * 2003-09-26 2012-09-26 알자 코포레이션 오피오이드 및 비오피오이드 진통제의 제어 방출 제제
KR20060076318A (ko) * 2003-09-26 2006-07-04 알자 코포레이션 밴딩 엔진을 포함하는 개선된 방출제어용 제형
CA2540045A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Dosage form for controlled release of an active agent formulation
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
MXPA06005462A (es) * 2003-11-14 2006-12-15 Johnson & Johnson Liberacion controlada de topiramato en formas de dosificacion liquida.
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
JP2007517063A (ja) * 2003-12-29 2007-06-28 アルザ・コーポレーシヨン トピラメートの新規な薬剤組成物および剤形
MXPA06007509A (es) * 2003-12-29 2007-10-18 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas.
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060257484A1 (en) * 2005-04-19 2006-11-16 Hwang Stephen S Combination of tramadol and substances that comprise gabapentin
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
WO2008052219A2 (en) * 2006-10-27 2008-05-02 Goody Products, Inc. Therapeutics styling tool with infusion delivery
US7845360B2 (en) 2006-10-27 2010-12-07 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US7832413B2 (en) * 2006-10-27 2010-11-16 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
CN102257120A (zh) * 2008-12-18 2011-11-23 Adds制药有限责任公司 吹塑薄壁的给药胶囊
EP2481399B1 (de) 2009-08-18 2015-11-25 Tohoku University Wirkstofffreisetzungssystem mit langzeitwirkung
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5213809A (en) * 1990-01-24 1993-05-25 Alza Corporation Delivery system comprising means for controlling internal pressure
KR920005648B1 (ko) * 1990-03-31 1992-07-11 정종평 항생활성 성분의 치과용 국소 지속성 투여 조성물
ES2065178T3 (es) * 1991-01-30 1995-02-01 Alza Corp Dispositivo osmotico para el suministro retardado de un agente.
CA2065966A1 (en) * 1991-04-23 1992-10-24 Robert J. Petcavich Disposable recyclable plastic articles and moldable synthetic resin blends for making the same
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form

Also Published As

Publication number Publication date
EP0782440A1 (de) 1997-07-09
DE69521901T2 (de) 2001-11-15
AU3966095A (en) 1996-05-23
ZA958892B (en) 1996-07-05
WO1996013248A1 (en) 1996-05-09
AU695739B2 (en) 1998-08-20
EP1057478A3 (de) 2001-09-19
US5614578A (en) 1997-03-25
NZ295982A (en) 1998-05-27
DE69531263D1 (de) 2003-08-14
ATE244554T1 (de) 2003-07-15
DE69531263T2 (de) 2004-05-13
KR100451782B1 (ko) 2004-10-08
DE69521901D1 (de) 2001-08-30
US5830502A (en) 1998-11-03
CA2200746A1 (en) 1996-05-09
MX9703111A (es) 1997-07-31
EP1057478B1 (de) 2003-07-09
CY2489B1 (en) 2005-06-03
JPH10508023A (ja) 1998-08-04
EP1057478A2 (de) 2000-12-06
KR20030097606A (ko) 2003-12-31
KR970706793A (ko) 1997-12-01
KR100408103B1 (ko) 2004-04-14
EP0782440B1 (de) 2001-07-25
CA2200746C (en) 2007-11-20
ES2203395T3 (es) 2004-04-16

Similar Documents

Publication Publication Date Title
ATE203396T1 (de) Spritzgegossene darreichungsform
DE69329878D1 (de) Mri-zusammensetzungen, basiert auf poly(alkylenoxid)
BR9609176A (pt) Composi-{es de agente biolÄgico
DE69023948T2 (de) Herstellung von peroxidhaltigen Perfluorpolyethern.
DE68906366T2 (de) CD4-Polypeptidderivate.
DE69115050D1 (de) Polymermembran.
FI892377A0 (fi) Ny polymerkomposition.
IT8921066A0 (it) Composizioni polimeriche autoestinguenti.
DE69018323D1 (de) Formkörper.
DE3889045T2 (de) Thermoplastische Äthylenpolymer-Zusammensetzung.
FI910695A0 (fi) Polymera foertjockningsmedel foer vattenbaserade belaeggningar.
IT9021421A0 (it) Composizioni polimeriche autoestinguenti.
DE69005751D1 (de) Herstellung von thermoplastischen Elastomerzusammensetzungen.
DE69114427D1 (de) Verbesserte Polymermembranen.
DE69006035D1 (de) Kunststoffversiegelung.
DE69020448D1 (de) Herstellung von Propylenoxid.
DE68916717D1 (de) Selbstverlöschende Polymer-Zusammensetzung.
DE69108020T2 (de) Polymerzusammensetzung, und daraus hergestellte Formkörper.
FI874215A (fi) Polymermodifierade, omaettade polyester- eller polyesteramidhartser och ur dessa framstaelld polymerbetong.
ATE154377T1 (de) Elastomere zusammensetzungen aus mischungen von elastomeren copolyestern und äthylen-äthylacrylat-copolymeren
DE58906999D1 (de) Oxetanylgruppen enthaltende thermoplastische Formmassen.
DE3780594T2 (de) Selbstverloeschende polymerzusammensetzung.
DE68911108T2 (de) Herstellung von Poly(arylether/thioether)-polyester-Blockcopolymeren.
DE59001405D1 (de) Polymermischung.
NO910004D0 (no) Hydrolyserbar silikonpolymer.